Abstract

Introduction:The coronavirus disease 2019 (COVID-19) has negatively impacted healthcare services worldwide. We hypothesized that the pandemic would affect our case mix and mortality. Our objective was to study this impact.Methods:We retrospectively studied all patients who underwent congenital heart surgeries from March 21st to August 21st in 2019 and 2020 using the institutional electronic database. We compared demographic data, preoperative and postoperative length of stay (LOS), risk stratification using Risk Adjustment for Congenital Heart Surgery (RACHS) classification and outcomes in both periods.Results:We observed a 66.7% decrease in our surgical volume (285 × 95 patients). Patients operated in the pre-pandemic period were older (911.3 [174.8 - 5953.8] days-old) compared to the pandemic period (275 days-old; P<0.05). When the case mix was compared between periods, the percentage of neonatal surgery was increased in the pandemic era (8% × 21.1%; P<0.05), and the number of RACHS 1-2 surgeries decreased significantly (60.7 × 27.4%; P<0.05). Preoperative LOS was increased in the pandemic period (1.2 × 7 days; P=0.001). There was no significant increment in mortality (P=0.1). Two patients tested positive for COVID-19 in the postoperative period and both died.Conclusion:Our program observed a sudden decrease in surgical volume and a consequent increase in surgical complexity. There was a non-significant increment in mortality.

Highlights

  • The coronavirus disease 2019 (COVID-19)has negatively impacted healthcare services worldwide

  • When the case mix was compared between periods, the percentage of neonatal surgery was increased in the pandemic era (8% × 21.1%; P

  • Preoperative length of stay (LOS) was increased in the pandemic period (1.2 × 7 days; P=0.001)

Read more

Summary

Introduction

The coronavirus disease 2019 (COVID-19)has negatively impacted healthcare services worldwide. In March 2020, almost four months after the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human infection was reported in Wuhan province, China, the first imported case of novel coronavirus disease 2019 (COVID-19) was confirmed in Brazil. At this time, the disease had already shown its complexity around the world, given the high transmission rate (R0 = 1.4–3.8) and a large number of hospitalizations needing intensive care and ventilation support, and exposed the frailty of all the best healthcare systems known[1,2,3].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call